Cali, J.; Chevallier, O.; Guillen, K.; Latournerie, M.; Mazit, A.; Aho-Glélé, L.S.; Loffroy, R.
Selective Arterial Embolization of Ruptured Hepatocellular Carcinoma with N-Butyl Cyanoacrylate and Lipiodol: Safety, Efficacy, and Short-Term Outcomes. J. Pers. Med. 2023, 13, 1581.
https://doi.org/10.3390/jpm13111581
AMA Style
Cali J, Chevallier O, Guillen K, Latournerie M, Mazit A, Aho-Glélé LS, Loffroy R.
Selective Arterial Embolization of Ruptured Hepatocellular Carcinoma with N-Butyl Cyanoacrylate and Lipiodol: Safety, Efficacy, and Short-Term Outcomes. Journal of Personalized Medicine. 2023; 13(11):1581.
https://doi.org/10.3390/jpm13111581
Chicago/Turabian Style
Cali, Jory, Olivier Chevallier, Kévin Guillen, Marianne Latournerie, Amin Mazit, Ludwig Serge Aho-Glélé, and Romaric Loffroy.
2023. "Selective Arterial Embolization of Ruptured Hepatocellular Carcinoma with N-Butyl Cyanoacrylate and Lipiodol: Safety, Efficacy, and Short-Term Outcomes" Journal of Personalized Medicine 13, no. 11: 1581.
https://doi.org/10.3390/jpm13111581
APA Style
Cali, J., Chevallier, O., Guillen, K., Latournerie, M., Mazit, A., Aho-Glélé, L. S., & Loffroy, R.
(2023). Selective Arterial Embolization of Ruptured Hepatocellular Carcinoma with N-Butyl Cyanoacrylate and Lipiodol: Safety, Efficacy, and Short-Term Outcomes. Journal of Personalized Medicine, 13(11), 1581.
https://doi.org/10.3390/jpm13111581
